Volume 34, Issue 241 (1-2025)
J Mazandaran Univ Med Sci 2025, 34(241): 79-88 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nakhaie M, Nakhaie S, Farsiu N, Sinaei R, Charostad J, Torabian S, et al . Relationship Between Mycoplasma Pneumoniae Serological Findings and Clinical Outcomes in COVID-19 Patients: A Cross-Sectional Study. J Mazandaran Univ Med Sci 2025; 34 (241) :79-88
URL: http://jmums.mazums.ac.ir/article-1-21408-en.html
URL: http://jmums.mazums.ac.ir/article-1-21408-en.html
Mohsen Nakhaie 
, Samira Nakhaie , Niloofar Farsiu , Reza Sinaei , Javad Charostad , Soheila Torabian , Sara Pezeshki , Faranak Salajegheh
, Samira Nakhaie , Niloofar Farsiu , Reza Sinaei , Javad Charostad , Soheila Torabian , Sara Pezeshki , Faranak Salajegheh
Abstract: (415 Views)
Background and purpose: Mycoplasma pneumoniae, which causes respiratory tract infections, has been associated with COVID-19 co-infections. This study aimed to investigate serum M. pneumoniae IgM and IgG levels in COVID-19 patients, assessing their connections with disease outcomes, including disease severity and mortality.
Materials and methods: For this cross-sectional investigation, 70 COVID-19 patients hospitalized at Afzalipour Hospital in Kerman, Iran, during the first wave of the pandemic were chosen. Serum IgM and IgG levels for M. pneumonia were clinically tested, and demographic and clinical data were gathered using a review of medical records. The data were analyzed using SPSS version 23.
Results: The research found a low incidence of M. pneumoniae IgM, while a considerable number of patients had positive IgG. Serum IgM levels differed depending on demographic and clinical characteristics, with younger patients and those without comorbidities having higher levels. Co-infected individuals experienced more frequent symptoms, such as anorexia, myalgia, and a productive cough. Patients who recovered had significantly higher levels of IgG than those who did not survive. Co-infection or past exposure to M. pneumoniae may impact COVID-19 clinical outcomes. Elevated blood IgM levels were associated with particular symptoms, whereas higher IgG levels were linked to better outcomes.
Conclusion: Previous or co-infection with M. pneumoniae can affect the symptoms and outcomes of COVID-19. Therefore, diagnosing co-infections with this bacterium can significantly improve the management and recovery of these patients.
Materials and methods: For this cross-sectional investigation, 70 COVID-19 patients hospitalized at Afzalipour Hospital in Kerman, Iran, during the first wave of the pandemic were chosen. Serum IgM and IgG levels for M. pneumonia were clinically tested, and demographic and clinical data were gathered using a review of medical records. The data were analyzed using SPSS version 23.
Results: The research found a low incidence of M. pneumoniae IgM, while a considerable number of patients had positive IgG. Serum IgM levels differed depending on demographic and clinical characteristics, with younger patients and those without comorbidities having higher levels. Co-infected individuals experienced more frequent symptoms, such as anorexia, myalgia, and a productive cough. Patients who recovered had significantly higher levels of IgG than those who did not survive. Co-infection or past exposure to M. pneumoniae may impact COVID-19 clinical outcomes. Elevated blood IgM levels were associated with particular symptoms, whereas higher IgG levels were linked to better outcomes.
Conclusion: Previous or co-infection with M. pneumoniae can affect the symptoms and outcomes of COVID-19. Therefore, diagnosing co-infections with this bacterium can significantly improve the management and recovery of these patients.
Type of Study: Research(Original) |
Subject:
Medical Virology
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
